TRIUS THERAPEUTICS SHAREHOLDER ALERT: Levi & Korsinsky Investigates Possible Breaches of Fiduciary Duty by Board of Trius The...
01 Agosto 2013 - 5:20PM
Business Wire
Levi & Korsinsky is investigating the Board of Directors of
Trius Therapeutics, Inc. (“Trius” or the “Company”) (Nasdaq: TSRX)
for possible breaches of fiduciary duty and other violations of
state law in connection with the sale of the Company to Cubist
Pharmaceuticals, Inc. (Nasdaq: CBST).
Click here to learn more about the investigation
http://zlk.9nl.com/trius-therapeutics-tsrx/, or call:
877-363-5972. There is no cost or obligation to you.
Under the terms of the transaction, Trius shareholders will
receive $13.50 in cash for each share of Trius stock they own.
Trius shareholders will also be eligible to receive one Contingent
Value Right of up to $2.00 per share should certain commercial
milestones be met. The investigation concerns whether the Trius
Board of Directors breached their fiduciary duties to stockholders
by failing to adequately shop the Company before agreeing to enter
into the transaction, and whether Cubist Pharmaceuticals, Inc. is
underpaying for Trius, thus unlawfully harming Trius shareholders.
In particular, at least one analyst set a price target for Trius
stock at $20.00 per share.
If you own common stock in Trius and wish to obtain additional
information, please contact Joseph E. Levi, Esq. either via email
at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free:
(877) 363-5972, or visit
http://zlk.9nl.com/trius-therapeutics-tsrx/.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey and Washington D.C. The firm has extensive
expertise in prosecuting securities litigation involving financial
fraud, representing investors throughout the nation in securities
and shareholder lawsuits. The attorneys at Levi & Korsinsky
have been appointed by numerous courts throughout the country to
serve as lead counsel on behalf of shareholders in major securities
lawsuits and have successfully recovered multimillion-dollar
damages awards on behalf of investors. For more information, please
feel free to contact any of the attorneys listed below. Attorney
advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLPJoseph Levi, Esq.Eduard Korsinsky,
Esq.Tel: 212-363-7500Toll Free: 877-363-5972Fax:
212-363-7171www.zlk.com
Grafico Azioni Trius Therapeutics, Inc. (MM) (NASDAQ:TSRX)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Trius Therapeutics, Inc. (MM) (NASDAQ:TSRX)
Storico
Da Lug 2023 a Lug 2024
Notizie in Tempo Reale relative a Trius Therapeutics, Inc. (MM) (NASDAQ): 0 articoli recenti
Più Levi & Korsinsky, LLP Articoli Notizie